Pages: ( 1 ) 2 3 4 5 6

12.04.2010
Congenix is pleased to announce that Mr. Luis D. Encarnacion joined our company bringing more than 8 years of business development experience... more

25.02.2010
Congenix is pleased to announce that they have been chosen to participate in a Phase II study for the treatment of rheumatoid arthritis with the use of monoclonal antibodies... more

11.12.2009
Vladimir Novakovskiy, MD, Ph.D., Managing Director and co-founder of Congenix will be attending this year’s BioPartnering North America 2010... more